Biology of Serine Proteases and Serpins
丝氨酸蛋白酶和丝氨酸蛋白酶抑制剂的生物学
基本信息
- 批准号:6869656
- 负责人:
- 金额:$ 35.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1992
- 资助国家:美国
- 起止时间:1992-08-01 至 2008-11-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Regulated proteolysis is used to drive many biological processes, including the cell cycle, cell death, and embryonic patterning. It is also thought to mediate complex brain functions such as learning and memory. Not surprisingly, then, defects in regulated proteolysis lead to human pathologies such as cancer and neurodegenerative disease. The overall goal of this grant is to understand the mechanisms of regulated proteolysis involving the coordinated action of serine proteases and their inhibitors called serpins. Three specific aims are proposed: 1) To test the hypothesis that a serpin is an inhibitor of proconvertases, serine proteases that activate a wide range of cellular and pathogenic proteins, including hormones, growth factors, and virulence determinants. 2) To identity serine proteases involved in the melanization reaction, an insect
analogue of the mammalian blood clotting reaction and a critical determinant of malarial resistance in the mosquito. 3) To perform an RNAi-based screen for serpin function that ultimately will lead to the identification of new biological processes involving serine proteases and serpins. These studies will exploit Drosophila, which utilizes many of the same molecular and cellular mechanisms as mammals, to learn general principles of how regulated proteolysis involving serine proteases and serpins is used for diverse biological purposes.
调节蛋白水解作用用于驱动许多生物过程,包括细胞周期、细胞死亡和胚胎模式。人们还认为它可以调节学习和记忆等复杂的大脑功能。毫不奇怪,调节蛋白水解的缺陷会导致癌症和神经退行性疾病等人类疾病。该资助的总体目标是了解调节蛋白水解的机制,涉及丝氨酸蛋白酶及其抑制剂(丝氨酸蛋白酶抑制剂)的协调作用。提出了三个具体目标:1) 检验丝氨酸蛋白酶抑制剂是原转化酶抑制剂的假设,丝氨酸蛋白酶可激活多种细胞和致病蛋白,包括激素、生长因子和毒力决定子。 2)为了鉴定参与黑化反应的丝氨酸蛋白酶,昆虫
哺乳动物凝血反应的类似物,也是蚊子抗疟疾的关键决定因素。 3) 对丝氨酸蛋白酶抑制剂功能进行基于RNAi的筛选,最终将导致涉及丝氨酸蛋白酶和丝氨酸蛋白酶抑制剂的新生物过程的鉴定。这些研究将利用果蝇(果蝇利用许多与哺乳动物相同的分子和细胞机制)来了解涉及丝氨酸蛋白酶和丝氨酸蛋白酶抑制剂的调节蛋白水解如何用于不同生物学目的的一般原理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARL HASHIMOTO其他文献
CARL HASHIMOTO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARL HASHIMOTO', 18)}}的其他基金
Yale Postbaccalaureate Research Education Program
耶鲁大学学士后研究教育计划
- 批准号:
8636742 - 财政年份:2014
- 资助金额:
$ 35.27万 - 项目类别:
相似海外基金
Investigation of improvement of skeletal muscle function by RNA interference for prevention of frailty
通过 RNA 干扰改善骨骼肌功能预防衰弱的研究
- 批准号:
23K10830 - 财政年份:2023
- 资助金额:
$ 35.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
- 批准号:
10539405 - 财政年份:2022
- 资助金额:
$ 35.27万 - 项目类别:
Tissue Adhesive RNA Interference Nanoparticles to Block Progression of Posttraumatic and Spontaneous Osteoarthritis.
组织粘附 RNA 干扰纳米颗粒可阻止创伤后和自发性骨关节炎的进展。
- 批准号:
10688080 - 财政年份:2022
- 资助金额:
$ 35.27万 - 项目类别:
Using RNA interference to combat the worst emerging disease of wildlife
利用 RNA 干扰对抗野生动物最严重的新疾病
- 批准号:
DP220101361 - 财政年份:2022
- 资助金额:
$ 35.27万 - 项目类别:
Discovery Projects
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
- 批准号:
10677770 - 财政年份:2022
- 资助金额:
$ 35.27万 - 项目类别:
Regulation of RNA interference pathways by extracellular cues
细胞外信号对 RNA 干扰途径的调节
- 批准号:
RGPIN-2019-04411 - 财政年份:2022
- 资助金额:
$ 35.27万 - 项目类别:
Discovery Grants Program - Individual
CAREER: Investigating the Role of an RNA Interference Pathway in Safeguarding the Tetrahymena Thermophila Somatic Genome
职业:研究 RNA 干扰途径在保护嗜热四膜虫体细胞基因组中的作用
- 批准号:
2143019 - 财政年份:2022
- 资助金额:
$ 35.27万 - 项目类别:
Continuing Grant
New Cancer Therapy: A Combination of RNA Interference and Gene Therapy
新的癌症疗法:RNA干扰和基因疗法的结合
- 批准号:
486535 - 财政年份:2022
- 资助金额:
$ 35.27万 - 项目类别:
Studentship Programs
RNA Interference and Heterochromatic Silencing in Replication and Quiescence
复制和静止过程中的 RNA 干扰和异染色质沉默
- 批准号:
10330828 - 财政年份:2022
- 资助金额:
$ 35.27万 - 项目类别:
CAREER: Abiotic degradation of emerging RNA interference pesticides
职业:新兴 RNA 干扰农药的非生物降解
- 批准号:
2046602 - 财政年份:2021
- 资助金额:
$ 35.27万 - 项目类别:
Continuing Grant














{{item.name}}会员




